Page 25 - Recursion Pharmaceuticals News Today

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) COO Tina Marriott Larson sold 3,000 shares of the stock in a transaction dated Thursday, August 24th. The stock was sold at an average price of $8.66, for a total transaction of $25,980.00. Following the completion of the sale, the chief operating officer now directly owns 418,782 […]

/PRNewswire/ -- The "Global Markets for Artificial Intelligence in Drug Discovery" report has been added to ResearchAndMarkets.coms offering. The current...

Platinum Investment Management Ltd. grew its position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 2.2% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,770,451 shares of the company’s stock after buying an additional 60,112 shares during the period. Platinum Investment Management Ltd.’s […]

BioPharma

You'll need to dig into company details, but the effort is worthwhile.

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) shares saw unusually-strong trading volume on Thursday . Approximately 1,231,280 shares traded hands during trading, a decline of 61% from the previous session’s volume of 3,169,160 shares.The stock last traded at $8.81 and had previously closed at $9.38. Analysts Set New Price Targets A number of analysts […]

Shares of Recursion Pharmaceuticals Inc. jumped more than 4% premarket on Thursday after chip giant Nvidia Corp. on Wednesday posted blowout quarterly...

The Ark Invest CEO continues to trim Shopify holdings to fund some big purchases.

The industry is changing rapidly, and for the better.

In this piece, we will take a look at billionaire Stanley Druckenmiller’s small-cap stock picks. If you want to skip our introduction to Mr. Druckenmiller and small-cap stocks in general, then head on over to Billionaire Stan Druckenmiller’s Small-Cap Stock Picks: Top 5 Stocks. Stanley Druckenmiller is one of the richest people in the world. […]